Related Experiment Video
Updated: May 31, 2026

The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
Published on: May 16, 2016
Simvastatin-induced meralgia paresthetica
Menahem Sasson1, Shvartzman Pesach
1Department of Family Medicine, Pain and Palliative Care Unit, Siaal Family Medicine and Primary Care Research Center, Ben-Gurion University of the Negev, Beer-Sheva 84105 Israel. sassonm@bezeqint.net
Abstract:
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) cause mainly muscular adverse effects. During the last 20 years there has been solid evidence of peripheral neuropathy caused by statins, with a risk of one in 10,000 patients treated for 1 year. Meralgia paresthetica is an entrapment neuropathy occasionally encountered by primary care physicians. To date there has been no report of entrapment neuropathy that could have been caused or aggravated by statins. This case report presents meralgia paresthetica aggravated by simvastatin use that disappeared after simvastatin cessation.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Myocarditis III: Medical Management
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists